Metabolic syndromea cluster of conditions including elevated blood pressure, blood sugar, and triglyceridesqualifies patients for GLP-1 treatment regardless of BMI category
If you do need to take a dose early or late, note this in your log along with any side effects you experience, as this information can guide future dosing decisions and help your provider assess your treatment response
Physiol Rev 97:721766 Oneil PM, Birkenfeld AL, Mcgowan B et al (2018) Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Sources Ozempic vs
Meanwhile, Eli Lilly is working to expand its own GLP-1 therapy Zepbound (tirzepatide) to treat obstructive sleep apnea and last month reported data from the Phase III SURMOUNT-OSA trial, showing that the drug leads to significant improvements in disease severity.
Know what the 6-month offer actually requires before you factor it into your purchase decision